Panel on Gene-Modified Cell Therapies: Maximizing Vector Function and Payload Delivery, Jan 21, 2025, Advanced Therapies Week, Dallas

Reach out so we can discuss your lentiviral or retroviral vector de-risking and rapid GMP supply needs. Farzin Farzaneh, PhD Traci Kyes Nicholas Ostrout, Ph.D. Meredith Brown Elaine Rihn

And see you at the workshop! Gene-Modified Cell Therapies: Maximizing Vector Function and Payload Delivery.

Dive into strategies to enhance therapeutic outcomes by optimizing vector function and improving payload delivery. This is your chance to gain insights that could transform the future of advanced therapies.

Our Chief Scientific Officer Farzin Farzaneh, PhD will be joined by

Reuben Benjamin, Haematologist, King’s College London

Cécile Bauche, Chief Scientific Officer, Alaya Bio

Julie G. Allickson, PhD, Chief Technology Officer, Mayo Clinic

Tuesday, January 21, 2025
2:25 PM - 3:25 PM
Theater 2 (Workshops), Advanced Therapies Week 2025, Dallas

Sign up via the app if you're already registered.

Panel on Gene-Modified Cell Therapies: Maximizing Vector Function and Payload Delivery, Jan 21, 2025, Advanced Therapies Week, Dallas

Team ViroCell is on the road

If you’re looking for a lentiviral and retroviral vector CDMO, we’d love to connect

London New York